学科支持

广东药科大学高水平论文

当前位置: 首页-> 学科支持-> 广东药科大学高水平论文-> 正文

广东药科大学高被引论文详情(2023年11月)

发布时间:2023-11-14

本期广东药科大学共有26篇高被引论文,较上期减少2篇。其中广东药科大学作为第一作者或通讯作者单位的论文有15篇,具体信息见下表(以被引频次排名)。


广东药科大学高被引论文

序号

标题

广药大作者

来源期刊

学科

被引频次

出版年

1

THE PI3K/AKT   PATHWAY IN OBESITY AND TYPE 2 DIABETES

苏政权

(通讯作者)

INTERNATIONAL   JOURNAL OF BIOLOGICAL SCIENCES 14 (11): 1483-1496 2018

BIOLOGY &   BIOCHEMISTRY

587

2018

2

ASSOCIATION OF   BLOOD GLUCOSE CONTROL AND OUTCOMES IN PATIENTS WITH COVID-19 AND PRE-EXISTING   TYPE 2 DIABETES

郭姣

(通讯作者)

CELL METABOLISM   31 (6): 1068-+ JUN 2 2020

MOLECULAR   BIOLOGY & GENETICS

523

2020

3

INVESTIGATING   THE OPTIMAL SIZE OF ANTICANCER NANOMEDICINE

周秦

(第八作者)

PROCEEDINGS OF   THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 111 (43):   15344-15349 OCT 28 2014

CLINICAL   MEDICINE

438

2014

4

GEMCITABINE AND   CISPLATIN INDUCTION CHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA

王希成

(第十四作者)

NEW ENGLAND   JOURNAL OF MEDICINE 381 (12): 1124-1135 SEP 19 2019

CLINICAL   MEDICINE

416

2019

5

M2B MACROPHAGE   POLARIZATION AND ITS ROLES IN DISEASES

郭姣

(通讯作者)

JOURNAL OF   LEUKOCYTE BIOLOGY 106 (2): 345-358 AUG 2019

IMMUNOLOGY

327

2019

6

NETWORK   PHARMACOLOGY IN RESEARCH OF CHINESE MEDICINE FORMULA: METHODOLOGY,   APPLICATION AND PROSPECTIVE

郭姣

(通讯作者)

CHINESE JOURNAL   OF INTEGRATIVE MEDICINE 26 (1): 72-80 JAN 2020

CLINICAL   MEDICINE

296

2020

7

IN-HOSPITAL USE   OF STATINS IS ASSOCIATED WITH A REDUCED RISK OF MORTALITY AMONG INDIVIDUALS   WITH COVID-19

郭姣

(通讯作者)

CELL METABOLISM   32 (2): 176-+ AUG 4 2020

MOLECULAR   BIOLOGY & GENETICS

283

2020

8

CORE-SHELL   BIOPOLYMER NANOPARTICLE DELIVERY SYSTEMS: SYNTHESIS AND CHARACTERIZATION OF   CURCUMIN FORTIFIED ZEIN-PECTIN NANOPARTICLES

胡坤

(第一作者)

FOOD CHEMISTRY   182: 275-281 SEP 1 2015

AGRICULTURAL   SCIENCES

277

2015

9

RESEARCH   PROGRESS ON BERBERINE WITH A SPECIAL FOCUS ON ITS ORAL BIOAVAILABILITY

龙晓英

(通讯作者)

FITOTERAPIA 109:   274-282 MAR 2016

PHARMACOLOGY   & TOXICOLOGY

206

2016

10

ADIPOCYTE-SECRETED   EXOSOMAL MICRORNA-34A INHIBITS M2 MACROPHAGE POLARIZATION TO PROMOTE   OBESITY-INDUCED ADIPOSE INFLAMMATION

叶德伟

(第四作者)

JOURNAL OF   CLINICAL INVESTIGATION 129 (2): 834-849 FEB 1 2019

CLINICAL   MEDICINE

199

2019

11

RESVERATROL ENCAPSULATION   IN CORE-SHELL BIOPOLYMER NANOPARTICLES: IMPACT ON ANTIOXIDANT AND ANTICANCER   ACTIVITIES

胡坤

(通讯作者)

FOOD   HYDROCOLLOIDS 64: 157-165 MAR 2017

AGRICULTURAL   SCIENCES

193

2017

12

FABRICATION OF   BIOPOLYMER NANOPARTICLES BY ANTISOLVENT PRECIPITATION AND ELECTROSTATIC   DEPOSITION: ZEIN-ALGINATE CORE/SHELL NANOPARTICLES

胡坤

(第一作者)

FOOD   HYDROCOLLOIDS 44: 101-108 FEB 2015

AGRICULTURAL   SCIENCES

178

2015

13

ENHANCEMENT OF   CURCUMIN WATER DISPERSIBILITY AND ANTIOXIDANT ACTIVITY USING CORE-SHELL PROTEIN-POLYSACCHARIDE   NANOPARTICLES

胡坤

(通讯作者)

FOOD RESEARCH   INTERNATIONAL 87: 1-9 SEP 2016

AGRICULTURAL   SCIENCES

133

2016

14

STRUCTURAL   CHARACTERIZATION AND MACROPHAGE IMMUNOMODULATORY ACTIVITY OF A POLYSACCHARIDE   ISOLATED FROM GRACILARIA LEMANEIFORMIS

周林

(第七作者)

JOURNAL OF   FUNCTIONAL FOODS 33: 286-296 JUN 2017

AGRICULTURAL   SCIENCES

128

2017

15

IMMUNE-RELATED   LNCRNA TO CONSTRUCT NOVEL SIGNATURE AND PREDICT THE IMMUNE LANDSCAPE OF HUMAN   HEPATOCELLULAR CARCINOMA

洪伟峰

(附院、第一作者)

MOLECULAR   THERAPY-NUCLEIC ACIDS 22: 937-947 DEC 4 2020

BIOLOGY &   BIOCHEMISTRY

125

2020

16

ENCAPSULATION OF   RESVERATROL IN ZEIN/PECTIN CORE-SHELL NANOPARTICLES: STABILITY,   BIOACCESSIBILITY, AND ANTIOXIDANT CAPACITY AFTER SIMULATED GASTROINTESTINAL   DIGESTION

胡坤

(通讯作者)

FOOD HYDROCOLLOIDS   93: 261-269 AUG 2019

AGRICULTURAL   SCIENCES

115

2019

17

PREVENTION AND   TREATMENT OF COVID-19 USING TRADITIONAL CHINESE MEDICINE: A REVIEW

周良云

(第三作者)

PHYTOMEDICINE   85: - MAY 2021

PHARMACOLOGY   & TOXICOLOGY

107

2021

18

A COMPOSITE   HYDROGEL WITH CO-DELIVERY OF ANTIMICROBIAL PEPTIDES AND PLATELET-RICH PLASMA   TO ENHANCE HEALING OF INFECTED WOUNDS IN DIABETES

姚泽欣

(学生、第三作者)

ACTA   BIOMATERIALIA 124: 205-218 APR 1 2021

MATERIALS   SCIENCE

90

2021

19

UNDERESTIMATED   HEALTH RISKS: POLYSTYRENE MICRO- AND NANOPLASTICS JOINTLY INDUCE INTESTINAL   BARRIER DYSFUNCTION BY ROS-MEDIATED EPITHELIAL CELL APOPTOSIS

江俊莹

(学生、第八作者)

PARTICLE AND   FIBRE TOXICOLOGY 18 (1): - JUN 7 2021

PHARMACOLOGY   & TOXICOLOGY

71

2021

20

METRONOMIC   CAPECITABINE AS ADJUVANT THERAPY IN LOCOREGIONALLY ADVANCED NASOPHARYNGEAL   CARCINOMA: A MULTICENTRE, OPEN-LABEL, PARALLEL-GROUP, RANDOMISED, CONTROLLED,   PHASE 3 TRIAL

王希成

(第十七作者)

LANCET 398   (10297): 303-313 JUL 24 2021

CLINICAL   MEDICINE

62

2021

21

EF24 INDUCES   FERROPTOSIS IN OSTEOSARCOMA CELLS THROUGH HMOX1

林绍强

(通讯作者)

BIOMEDICINE   & PHARMACOTHERAPY 136: - APR 2021

PHARMACOLOGY   & TOXICOLOGY

57

2021

22

TNF ANTAGONIST   SENSITIZES SYNOVIAL FIBROBLASTS TO FERROPTOTIC CELL DEATH IN COLLAGEN-INDUCED   ARTHRITIS MOUSE MODELS

秦艺菲

(学生、第十作者)

NATURE COMMUNICATIONS   13 (1): - FEB 3 2022

CLINICAL   MEDICINE

43

2022

23

EFFECT OF   FIRST-LINE SERPLULIMAB VS PLACEBO ADDED TO CHEMOTHERAPY ON SURVIVAL IN   PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER THE ASTRUM-005   RANDOMIZED CLINICAL TRIAL

王希成

(第十二作者)

JAMA-JOURNAL OF   THE AMERICAN MEDICAL ASSOCIATION 328 (12): 1223-1232 SEP 27 2022

CLINICAL   MEDICINE

31

2022

24

THE   MICROSTRUCTURE, ANTIBACTERIAL AND ANTITUMOR ACTIVITIES OF CHITOSAN   OLIGOSACCHARIDES AND DERIVATIVES

苏政权

(通讯作者)

MARINE DRUGS 20   (1): - JAN 2022

PHARMACOLOGY   & TOXICOLOGY

25

2022

25

KAEMPFEROL   EXERTS A NEUROPROTECTIVE EFFECT TO REDUCE NEUROPATHIC PAIN THROUGH   TLR4/NF-KAPPA B SIGNALING PATHWAY

钱国强

(通讯作者),第二单位

PHYTOTHERAPY   RESEARCH 36 (4): 1678-1691 APR 2022

PHARMACOLOGY   & TOXICOLOGY

20

2022

26

TORIPALIMAB PLUS   CHEMOTHERAPY FOR PATIENTS WITH TREATMENT-NAIVE ADVANCED NON-SMALL-CELL LUNG   CANCER: A MULTICENTER RANDOMIZED PHASE III TRIAL (CHOICE-01)

王希成

(第六作者)

JOURNAL OF   CLINICAL ONCOLOGY 41 (3): 651-+ JAN 20 2023

CLINICAL   MEDICINE

12

2023



责任编辑:温玉琴